vs
AMERICAN REALTY INVESTORS INC（ARL）与Assertio Holdings, Inc.（ASRT）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是AMERICAN REALTY INVESTORS INC的1.0倍（$13.5M vs $13.0M），AMERICAN REALTY INVESTORS INC同比增速更快（8.1% vs -57.9%），过去两年AMERICAN REALTY INVESTORS INC的营收复合增速更高（4.6% vs -35.4%）
原温加顿地产投资者是一家房地产投资信托公司，主要投资于美国南部的购物中心，且项目大多以杂货店作为主力店。该公司在2021年8月被金考地产收购。
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
ARL vs ASRT — 直观对比
营收规模更大
ASRT
是对方的1.0倍
$13.0M
营收增速更快
ARL
高出66.0%
-57.9%
两年增速更快
ARL
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.0M | $13.5M |
| 净利润 | $9.8M | — |
| 毛利率 | — | — |
| 营业利润率 | -23.3% | -86.7% |
| 净利率 | 75.2% | — |
| 营收同比 | 8.1% | -57.9% |
| 净利润同比 | 6175.8% | — |
| 每股收益（稀释后） | $0.60 | $-4.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARLASRT
| Q4 25 | $13.0M | $13.5M | ||
| Q3 25 | $12.8M | $49.5M | ||
| Q2 25 | $12.2M | $29.2M | ||
| Q1 25 | $12.0M | $26.5M | ||
| Q4 24 | $12.0M | $32.2M | ||
| Q3 24 | $11.6M | $29.2M | ||
| Q2 24 | $11.8M | $31.1M | ||
| Q1 24 | $11.9M | $32.4M |
净利润ARLASRT
| Q4 25 | $9.8M | — | ||
| Q3 25 | $129.0K | $11.4M | ||
| Q2 25 | $2.8M | $-16.4M | ||
| Q1 25 | $3.0M | $-13.5M | ||
| Q4 24 | $-161.0K | — | ||
| Q3 24 | $-17.5M | $-2.9M | ||
| Q2 24 | $1.2M | $-3.7M | ||
| Q1 24 | $1.8M | $-4.5M |
营业利润率ARLASRT
| Q4 25 | -23.3% | -86.7% | ||
| Q3 25 | -12.3% | 23.2% | ||
| Q2 25 | -8.3% | -27.5% | ||
| Q1 25 | -6.8% | -50.0% | ||
| Q4 24 | -14.8% | -41.9% | ||
| Q3 24 | -17.8% | -10.4% | ||
| Q2 24 | -10.8% | -11.6% | ||
| Q1 24 | -12.7% | -13.4% |
净利率ARLASRT
| Q4 25 | 75.2% | — | ||
| Q3 25 | 1.0% | 23.1% | ||
| Q2 25 | 23.2% | -56.0% | ||
| Q1 25 | 24.7% | -51.1% | ||
| Q4 24 | -1.3% | — | ||
| Q3 24 | -150.4% | -10.0% | ||
| Q2 24 | 9.9% | -11.8% | ||
| Q1 24 | 14.7% | -13.9% |
每股收益（稀释后）ARLASRT
| Q4 25 | $0.60 | $-4.54 | ||
| Q3 25 | $0.01 | $0.11 | ||
| Q2 25 | $0.18 | $-0.17 | ||
| Q1 25 | $0.18 | $-0.14 | ||
| Q4 24 | $-0.01 | $-3.28 | ||
| Q3 24 | $-1.08 | $-0.03 | ||
| Q2 24 | $0.07 | $-0.04 | ||
| Q1 24 | $0.11 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.1M | $63.4M |
| 总债务越低越好 | $214.4M | — |
| 股东权益账面价值 | $617.4M | $94.0M |
| 总资产 | $1.1B | $267.0M |
| 负债/权益比越低杠杆越低 | 0.35× | — |
8季度趋势，按日历期对齐
现金及短期投资ARLASRT
| Q4 25 | $89.1M | $63.4M | ||
| Q3 25 | $82.8M | $93.4M | ||
| Q2 25 | $73.5M | $98.2M | ||
| Q1 25 | $88.7M | $87.3M | ||
| Q4 24 | $99.7M | $100.1M | ||
| Q3 24 | $131.6M | $88.6M | ||
| Q2 24 | $127.5M | $88.4M | ||
| Q1 24 | $130.9M | $80.7M |
总债务ARLASRT
| Q4 25 | $214.4M | — | ||
| Q3 25 | $227.0M | — | ||
| Q2 25 | $216.0M | — | ||
| Q1 25 | $201.7M | — | ||
| Q4 24 | $185.4M | — | ||
| Q3 24 | $183.8M | — | ||
| Q2 24 | $181.0M | — | ||
| Q1 24 | $181.8M | $38.6M |
股东权益ARLASRT
| Q4 25 | $617.4M | $94.0M | ||
| Q3 25 | $607.8M | $105.8M | ||
| Q2 25 | $607.8M | $93.3M | ||
| Q1 25 | $604.9M | $108.5M | ||
| Q4 24 | $601.8M | $121.1M | ||
| Q3 24 | $602.2M | $130.5M | ||
| Q2 24 | $619.9M | $132.2M | ||
| Q1 24 | $618.8M | $134.5M |
总资产ARLASRT
| Q4 25 | $1.1B | $267.0M | ||
| Q3 25 | $1.1B | $319.8M | ||
| Q2 25 | $1.1B | $273.8M | ||
| Q1 25 | $1.0B | $286.4M | ||
| Q4 24 | $1.0B | $284.7M | ||
| Q3 24 | $1.0B | $276.0M | ||
| Q2 24 | $1.0B | $279.4M | ||
| Q1 24 | $1.0B | $282.0M |
负债/权益比ARLASRT
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.6M | $-30.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | -0.57× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ARLASRT
| Q4 25 | $-5.6M | $-30.0M | ||
| Q3 25 | $8.0M | $-4.8M | ||
| Q2 25 | $-2.9M | $19.1M | ||
| Q1 25 | $-7.4M | $-12.5M | ||
| Q4 24 | $1.1M | $11.5M | ||
| Q3 24 | $13.5M | $-35.0K | ||
| Q2 24 | $-503.0K | $7.4M | ||
| Q1 24 | $3.9M | $7.5M |
资本支出强度ARLASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ARLASRT
| Q4 25 | -0.57× | — | ||
| Q3 25 | 61.81× | -0.42× | ||
| Q2 25 | -1.03× | — | ||
| Q1 25 | -2.50× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.43× | — | ||
| Q1 24 | 2.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARL
暂无分部数据
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
